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THE ROLE OF THE IMMUNE SYSTEM IN PERIODONTAL DISEASE 
SELENA FRANCIS 
ABSTRACT 
 
 
The role of the immune system in periodontal disease has been well established. 
Individuals who smoke are more prone to developing periodontitis because of the 
excess plaque buildup and the immune system’s attack of the bacteria on the 
gingiva. This study aims to examine the role of immunotherapy in the reversal of 
periodontal disease in individuals who smoke. Further research will not only 
assist with the reversal of periodontitis, but may also improve other debilitating 
co-morbid diseases including autoimmune diseases such as human 
immunodeficiency virus. To examine this question, a variety of research studies 
from various sources were examined.  
 
There are numerous factors, which contribute to the initiation and progression of 
periodontal disease. Use of nicotine products enhances the accumulation of 
plaque formation. Accumulation of large amounts of plaque and calculus assist in 
the progression of periodontal disease. Disease of the gingiva may lead 
numerous other debilitating diseases such as respiratory infections, Alzheimer’s 
disease and unfavorable pregnancy outcomes. 
 
v	  	  
Two components of the immune system play a major role in gingival 
inflammation observed in smokers; these include cytokine production and 
inflammation. The concentration of pro-inflammatory cytokines released from the 
macrophages of smokers is significantly higher than that observed in non-
smokers. Pro-inflammatory cytokines, such as TNF-alpha, are responsible for 
inflammation of the gingiva. The use of pre-existing immunotherapy treatments 
may be beneficial and assist in the reversal of periodontal disease.  
 
Further researcher on immune therapy, which has been shown to be successful 
in other disease treatments will not only be beneficial for the oral cavity, but for 
overall systemic health. Both immune and bacterial components should be taken 
into consideration when developing therapies for periodontal disease. Pro-
inflammatory cytokines such as TNF-alpha are dramatically increased in 
smokers. Researchers should model therapies after existing therapies that have 
been successful for other diseases such as immunotherapy studies with 
lamvidine (Hepatitis B), lambrolixumab (melanoma) and infliximad (oral plaque).  
 
The mTOR signaling pathway controls the release of pro-inflammatory and anti-
inflammatory cytokines. Deletion of the raptor protein causes more inflammation 
in the colon due to an increased release of pro-inflammatory cytokines. 
Therapies which directly act upon this signaling pathway should be further 
researched upon to reverse the effects of periodontal disease.  
vi	  	  
 
Chromogranin A release showed a significant increase in smokers because of 
the body’s ability to want to automatically attach the harsh environment created 
by tobacco. Modulating the immune response induced by Chromagranin A or 
possibly through the use of anti-TNF-alpha therapies which have shown success 
in patients with rheumatoid arthritis also is open to future research.  
 
The shift from gram-negative to gram-positive bacteria was noted in periodontal 
disease patients. The less diverse bacteria lead to the loss of the ability of 
ligaments to attach to one another in the oral cavity. The development and 
testing of bacteria specific antibiotics such as Fusobacterium, Prevotella, and 
Selenomonas may prove to be very beneficial.  There is much optimism among 
the dental professionals that immunotherapy may lead to  the development of 
future therapies for periodontitis in both smokers and non-smokers.  However  
we must also encourage patients to stop smoking through awareness and 
education. 
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INTRODUCTION 
 
Periodontitis, inflammation of the gums and the surrounding structures, can 
range in severity from gingival inflammation to complete tooth loss or eduntilism 
(Tonetti, 1998).  The association of periodontal diseases with many demographic 
(age), pathological (genetics, diabetes, hormones, stress) as well as 
environmental (smoking) factors has been demonstrated.  This paper will 
evaluate one of these environmental factors- smoking and nicotine products in 
particular (Table 1, Figure 1).  
 
Table 1:  Factors Affecting Periodontal Disease Development And 
Progression. Table taken from Manakil, 2012, pg.10.  
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Figure 1:  Risk Factors for Periodontal Disease.  There are many different 
factors contributing to periodontal disease including environmental, economic, 
local and systemic factors.  Figure taken from Novak, 2008. 
 
 
Before discussion of the effects of smoking specifically, one must understand the 
basic mechanism of periodontal disease and the role of the immune system in 
disease progression.  
 
Plaque Formation 
Periodontitis can be caused by a variety of factors, including dental plaque. 
Dental plaque is a biofilm that surrounds the tooth surface. The constituents of 
3	  	  
plaque range from different kinds of polymers to a wide variety of bacteria 
(Manakil, 2012). The bacteria contained within the plaque send out different 
chemicals and signals to communicate with the surrounding environment. The 
bacteria within the plaque use a variety of nutrients and growth factors to develop 
into larger masses. In order for bacteria to grow, they must communicate with 
one another through different mechanisms such as, quorum sensing. This type of 
communication results from the individual bacteria actually sensing the protein 
density surrounding them by secretion of chemicals by the adjacent bacteria. 
Without this growth, periodontal disease development will be considerably less 
(Palmer et al., 2001).  
 
The manner in which the biofilm is attached to the tooth surface is unique. It is 
basically a thin layer, which has bacterial projections in the shape of a mushroom 
projecting into the lumen of the enamel (Costerton et al., 1995). These 
projections allow the fluid in the lumen to freely pass through the microbial 
organism and the tooth surface. Figure 2 demonstrates how the biofilm adheres 
to the tooth surface. 
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Figure 2: Biofilm Adherence.  The biofilm is attached to the tooth with long 
bacterial projects that permit fluid movement within.  Figure taken from Costerton 
et al., 1995. 
 
 
Dental professionals have observed that dental plaque concentrations increase 
following inflammation of the gingiva (Rudiger et al., 2002). The process initiating 
plaque development is unclear but two mechanisms have been suggested by 
researchers. The first is that the amount of fluid in the gingiva increases 
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significantly during inflammation providing a better and larger supply of nutrients 
for the bacteria inhabiting the tooth surface biofilm. Another proposed 
mechanism is that plaque is increased due to the shift in the number and type of 
bacterial organisms in the plaque resulting from an increase in the amount of 
protein composed in the pellicle. The higher the concentration of protein secreted 
by the gingival margin, the easier it is for plaque to accumulate on the tooth 
surface. The shift of bacterial organisms with disease progression starts with 
gram-negative bacteria without filaments and rods and changes to gram-positive 
bacteria with filaments and rods (Rudiger et al., 2002). 
 
Bacteria are able to attach two to three times easier to surfaces that have 
rougher edges verses smooth edges thereby allowing primary attachment of the 
bacteria. This attachment allows the bacteria to hide in crevices shielding them 
from forces able to wash them away. The rougher edges of the tooth surface are 
shown to be more difficult to clean while brushing allowing the bacteria located in 
these areas to multiply more rapidly (Tueghels et al., 2006). During an oral exam, 
the amount of bacteria present on the tooth surface is measured by evaluating 
the two main structures of the tooth, the crown and the root. In periodontal 
disease the margin around the root of the tooth has a higher density of bacterial 
organisms (Nyvad and Fejerskov, 1987). 
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Calculus Formation 
When there is a hardening of dental plaque on the tooth surface, dental calculus 
is formed due to mineralization.  Calculus is a cement-like substance and can 
form on both the subgingival and surpragingival margin (Figure 3). Subgingival 
calculus occurs beneath the gums and is limited to the tooth surface while the 
supragingival calculus can occur on the dentin, cementum and the enamel. The 
clinical observation of subgingival calcus differs greatly from supragingival 
calculus. Subgingival deposits are black/brown in color, while supragingival 
calculus is white/yellow (Clarehugh, 2000). This difference is due to the fact that 
the calculus can reach these areas when recession is seen in patients (White, 
1997). Table 2 presents effects observed when calculus is present on both 
surfaces.  
 
The mechanism of calculus formation involves calcium ions binding to 
carbohydrate protein complexes. This will eventually lead to a precipitation, 
which consists of calcium phosphate salts. Calculus formation is due to a 
layering of thin layers of plaque.  Figure 3 below depicts calculus deposits on the 
subgingival and supragingival margin. 
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Figure 3: Calculus Deposits. Image of control and calculus deposits on 
subgingival and supragingival margins. Figure taken from White, 1997. 
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Table 2:  Characteristics of Supragingival and Subgingival Calculus.  
Calculus affects the color, distribution, composition, of the tooth and differences 
exist in each depending on the surface exposed. Table amended from Roberts-
Harry and Clerehugh, 2000. Abbreviations: Ca (calcium), Mg (magnesium), F 
(fluoride), Sr (strontium ) Zn (zinc) 
 
 
 Supragingival Subgingival 
Location Coronal to gingival margin Apical to gingival margin 
Colour Yellow/White Brown/Black 
Distribution Adjacent to salivary duct 
openings 
Randomly around mouth 
Composition Concentration of Ca, Mg, F, Sr 
& Zn lower and of carbonate & 
Mn higher than subgingival 
calculus. More regular 
distribution of F 
Concentration of Ca, Mg & F higher 
and of carbonate lower than 
supragingival calculus. More 
irregular distribution of F 
Mineral content 
& source 
Averages 37% from saliva by 
volume 
Averages 58% from gingival 
crevicular fluid by volume 
 
Formation Heterogeneous nucleation & 
crystal growth.  
Heterogeneous nucleation & crystal 
growth.  
 
Microorganisms Dominated by microorganisms; 
some non-calcified areas. More 
filamentous organisms; faster 
growth 
Very few non-calcified 
microorganisms. Less filamentous 
organisms; slower growth 
Influence of 
race 
Greater prevalence & quantities 
in Asian populations 
Greater prevalences in Asian 
populations associated with more 
extensive attachment loss. Lower 
levels of sodium and magnesium in 
more apical subgingival calculus in 
Indo-Pakistanis than in Caucasians 
 
Morphology Undifferentiated Several types identified: spiny, 
crusty, nodular; ledge/ring; 
individual islands; smooth veneers; 
finger/fernlike; supra- on 
subgingival 
 
Pathogenic 
potential 
Little evident Associated with periodontal disease 
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Calculus, Gingivitis and the Role of the Immune System 
Researchers have been studying whether or not dental calculus has an effect on 
gingivitis. There have been numerous studies showing the correlations between 
the presence of dental calculus and the degree of gingival recession (Rustogie et 
al., 1991; Joshipura et al., 1994, Mumghamba et al., 2009; Chrysanthakopoulos, 
2011). A study done on 260 young adults with varying degrees of calculus 
provided evidence on the correlation between calculus and ginigival recessions. 
Those individuals with mild calculus showed a mild degree of recession while 
those with excessive amounts of dental calculus showed a much greater degree 
of recession (Joshipura et al., 1994).   
 
Subginigival calculus is also associated with pocket formation on the gingival 
margin and loss of attachment in the periodontal tissue. Due to these 
observations, there is a high correlation between a faster progression of 
periodontal disease and the presence of dental calculus (Ower, 2013). When 
lesions were formed in an individual with dental calculus, the lesion was found to 
progress at a higher rate than in those individuals without calculus (Christersson 
et al., 1992). 
 
The increase in bacteria on the tooth surface will eventually lead to an immune 
attack on the gingiva. The immune system is able to fight against the bacterial 
buildup and the harsh environment through deployment of different types of cells 
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including T-cells, B-cells, macrophages, mast cells, and natural killer cells 
(Manakil, 2012)  
 
There are two main components of the immune system, the innate immune 
system and the adaptive immune system (Schwartz et al, 1995). The innate 
system is responsible for the release of mediators such as inflammatory 
cytokines and chemokines. This response is considered non-specific. The innate 
system responds immediately when a pathogen enters the body and does not 
require any memory for initiation. Unlike the adaptive immune system, the innate 
system is a silent response and does not usually cause inflammation in the area 
of attack. If there is inflammation due to the innate system it would be due to an 
excessive amount of attack (Si-Tahar et al., 2009).  
 
The main cells that are deployed by the innate immune system are natural killer 
cells, macrophages, polymorphonuclear neutrophils, mast cells, and eosinophils. 
The cells function to directly kill the pathogen that has entered the body. In order 
to be directed to the correct location in the body, the epithelial cells which are the 
first to sense the foreign pathogen release cytokines and chemokines. The 
release of these substances then directs the different innate cells to the correct 
location. Certain innate cells like the macrophages release additional cytokines to 
recruit even more cytokines (Si-Tahar et al., 2009). 
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The adaptive immune response uses strategies such as recognizing pathogens 
through memory. The main components of the adaptive immune response are 
the B cells, T cells, antigen presenting cells (APC’s) and dendritic cells (Parija, 
2009). The B-cells are the cells which mainly produce antibodies while the T cells 
can either be the helper cells or the regulatory cells. The two types of T cells 
release a variety of cytokines such as interleukin (IL)-2, interferon gamma, and 
lymphotoxin alpha. There are also two types of helper cells and their functions 
are to either help in isotype switching in B cells and up-regulate macrophage 
activation or for clonal expansion.   
 
When a pathogen is recognized by a dendritic cell, dendritic cells travel to the 
lymph node and interact with both the B cells and the T cells. When the dendritic 
cell interacts with the B cells, antibodies are produced for memory recognition. 
When the dendritic cell interacts with the T cell, CD4+ and CD8+ cells are 
produced. The dendritic cell here is the antigen presenting cell since it presents 
the antigen to the B and T cells (Berghlundh and Donati, 2005). The antibodies 
produced will assist in future attacks of the same pathogen. The body will be able 
to deploy its adaptive immune defenses in a much quicker fashion since the 
antibodies have already been produced. 
 
If there is an overabundance of bacteria in the gingiva, there will be a stronger 
inflammatory response initiated by the immune system and will result in a higher 
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degree of periodontitis. When looking at healthy gums compared to those with 
gingivitis, visible inflammation and bleeding can be seen in (Figure 4). 
 
 
Figure 4:  Images of Control and Periodontal Diseased Gums.  Shown is the 
progression of periodontal disease in healthy gingiva (top left) through the 
gingivitis  (top right) and moderate and severe periodontitis (bottom left and right, 
respectively). Figure taken from hopkinsarthristis.org.   
 
 
There are many factors that can lead to periodontitis such as a change in the 
micro-biome of the oral cavity, an increase in the inflammatory response by the 
immune system, and the production of periodontal ligament fibroblasts. Different 
types of bacteria are shown to cluster together in specific patterns influencing 
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colonization on the tooth surface (Socransky et al., 2008). Bacteria, such as 
Streptococcus sanguinis, can link to bacteria such as Corynebacterium 
matruchotti which is unable to colonize. Without the process of clustering, the 
initiation of plaque formation would not be possible (Sprodone and Bortolaia, 
2003). 
 
The Role of Smoking in Periodontal Disease Progression 
Smoking has been linked to periodontal disease (Figure 5) (Tomar, 2000). Other 
than an individual’s genetic disposition for periodontal disease, smoking is the 
most relevant, independent, risk factor in its development (Tomar, 2000). Figure 
5 summarizes the role of smoking in the oral cavity (Page and Kornman, 1997). 
The oral cavity is challenged by microbial bombardment which eventually leads 
the immune system to increase its host response. An increase in the host 
inflammatory response in the oral cavity can cause both connective tissue and 
bone metabolism upregulation. Once this occurs, clinical signs in the oral cavity 
are evident through inflammation. The greater the degree inflammation, the 
easier it is for bacteria to replicate, resulting in even more inflammation.   
 
Smoking is also a major cause in the suppression of the immune system (Ojima 
& Hanioka, 2010). When the body is exposed to chemicals from cigarettes, T-
cells are not are not able to proliferate as efficiently. Studies have shown that 
there was a significant decrease in the number of CD4 cells, cells that are critical 
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in the production of antibodies from B cells (Manakil, 2012). There are increases 
in the number of macrophages in the lung and the oral cavity but their function is 
compromised (Barbour, 1997). An optimal working macrophage will be able to 
release cytokines, which are able to coordinate more of the immune response. 
Without properly functioning T cells, B cells, and macrophages, the body will not 
be able to fight against the harsh environment caused by cigarette smoking. 
Cytokines are able to coordinate the immune response through signaling when 
there is a pathogen or foreign assault on the body. Through suppression of 
cytokines, such as IL-1, IL-6, and an increase in tumor necrosis factor alpha 
(TNF-α), the body cannot efficiently protect itself from these foreign invaders 
(Zeidel, 2002). 
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Figure 5: Smoking Affects Both the Development and Progression of 
Periodontal Disease.  Smoking triggers a variety of effects in the oral cavity 
including changes in host defense system, subgingival environment, destruction 
of matrix and bone and compromised wound healing.  Together these events 
advance periodontal disease.  Figure taken from Periobasics.com.  	  	  
 
Not only does smoking have an effect on the immune system, but has been 
shown to have a direct correlation with the risk of developing dental caries 
(Figure 6). Individuals who have never smoked have a 50% less chance of a risk 
for developing caries. Smokers have almost a fifty percent chance for developing 
caries.  
 
 
Fi
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Figure 6: Prevalence of Caries in Smokers. Individuals that smoked but have 
stopped can reduce their risk of caries relative to current smokers.  Figure taken 
from Kelley et al., 2000. 
 
 
 
The appearance of calculus is also affected by other environmental factors such 
as food and nicotine. If individuals are heavy smokers, their calculus will be a 
darker color because of the pigment of the smoke. Artificial food coloring can 
also have an effect on the color of the calculus. Calculus formation can form in 
many and all areas of tooth surfaces but there are areas more susceptible then 
others. The two areas with the highest prevalence of calculus are the buccal and 
lingual surfaces (Corbett and Dawes, 1998).   
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Those who smoke are shown to have more damage to their gingiva because the 
disease is able to progress at a faster rate (Manakil, 2012). Cigarettes are 
composed of up to four thousand different types of chemicals. These chemicals 
expose the body to a harsh environment leading to release of a variety of 
inflammatory cytokines. Smokers are two to three times more likely to develop 
periodontal disease than individuals who do not expose their gums to such a 
harsh environment and stress (Tonetti, 1998). A summary of the immune, 
vascular and inflammatory responses observed in smokers is shown in Figure 7.   
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Figure 7: Destructive effects of smoking on periodontal tissue. Smoking 
effects are wide and can be categorized with as vascular, immune, or 
inflammatory responses.  Figure taken from Ojima & Hanioka, 2010. 
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Scientists have now linked smoking to the weakening of the immune defenses, 
causing a faster rate of progression of periodontal disease (Manakil, 2012). The 
faster rate of progression of periodontal disease also includes a higher 
prevalence of caries. The Department of Health conducted a study on individuals 
residing in the United Kingdom and who were active smokers (Kelly et al., 2000). 
The prevalence of dental caries in those individuals who smoked was almost two 
times higher than non-smokers. A compromised immune system will not only 
allow the progression of periodontal disease but allows for the incapability to fight 
infections (Delta Dental, n.d.). In order to fully fight foreign pathogens, the body 
must have all of its immune components fully working to fight against these 
pathogens. 
 
Different types of bacteria protect the gingiva from various assaults and stresses 
such as nicotine use (Figure 8)(Kumar et al., 2011). Individuals who smoked 
were shown to have a shift in the type of bacteria that inhabited their mouth. The 
type of bacteria that were seen in a smoker’s gingiva is usually attributed to some 
sort of disease because they are considered to be low on the taxonomic chart 
(Bizarro, 2013).  
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Figure 8:   Bacteria Shift in the Oral Cavity Due to Smoking.  Bacteria 
clustering between smokers (black) and non-smokers (white) varies. Figure 
amended from  Kumar et al., 2011. 
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Scientists have been investigating whether or not the effects of smoking are 
reversible. As early as 1973 a study by Cavaliere et al. demonstrated the 
depressed levels of leukocytes circulating systemically when exposed to tobacco 
smoke. Researchers calculated the length of time it took the body to recover after 
a forty-two week period of smoking. Significant results were displayed when 
smoking was halted.  More recently, Tomar and Asma (2000) and Torrungruang 
et al. (2005) linked smoking cessation to improved periodontitis. These kind of 
results show that cessation of smoking is never too late and should be 
considered in those who have been smoking long term.  
 
Sadaoka in 2013 measured the amount of chromogranin A in the gingiva of 
smokers and demonstrated a significant increase. The level of other 
inflammatory proteins as measured by immuno-staining also increased. The 
increase was higher in individuals who passively smoked, 10 nM of nicotine daily, 
when compared to individuals who actively smoke, 100 nM of nicotine daily 
(Sadaoka, 2013). 
 
Immune Therapy and Periodontal Disease 
Immune therapy is used to strengthen the patient’s immune system for a variety 
of reasons. One of the main diseases which immunotherapy is used is cancer. 
Immunotherapy acts either by boosting the immune system making it “smarter” 
and able to attack certain cells or by giving the patient’s immune system 
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components to fight off the disease. This type of treatment can be used to treat 
cancers and other diseases alone or in conjunction with other type of drugs 
(American Cancer Society, n.d.). 
 
A recent study conducted to elucidate the signaling pathway involved in cancer 
immunotherapy identified the mammalian target of rapamycin, mTOR (Katholnig 
et al., 2013). This pathway regulates the immune response through the release 
and activation of macrophages and dendritic cells. With an absence of this 
pathway, the body is not able to regulate its attack on tumors, cancerous agents, 
and other foreign substances. Manipulating macrophages and dendritic cells to 
attack tumorigenic cells will allow scientists to specifically (1) target an area of 
the body, (2) to control the duration of the attack, and (3) to regulate wound 
healing. A better understanding of this pathway, will allow researchers to better 
construct therapies for both cancer as well as periodontal disease patients 
(Katholnig et al., 2013). 
 
Effects of Periodontal Disease on Systemic Health 
Periodontal disease does not only affect the oral cavity but it also has a major 
impact on systemic health. Periodontal disease has been shown to be associated 
with a variety of medical outcomes such as renal disease, respiratory disease, 
unfavorable pregnancy outcomes, diabetes, inflammatory bowel disease and 
Alzheimer’s disease (Dumitrescu, 2009). 
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In a study by Kuo et al. (2008) the incidence of bacterial pneumonia in individuals 
with periodontal disease was observed to be significantly higher (Figure 9).   
 
 
 
 
 
 
 
 
Pneumonia is caused by bacterial entrance into the lungs or through 
nasopharyngeal fluid. Periodontal disease is associated with an increase in 
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microbial organisms in the oral cavity, increasing the probability of bacteria 
entering the lungs (McChlery et al., 2009).  Improvement of oral health has been 
correlated with a reduction in the occurrence of pneumonia.  Trials with oral 
application of antibiotics and oral applications of antiseptics were compared in 
patient with compromised respiratory systems. Oral antibiotics led to a significant 
decrease in the incidence of pneumonia (Chan et al., 2007). 
 
Complications such as gestational diabetes, still birth, and pre-term delivery in 
pregnant women, have been shown to increase when the woman has periodontal 
disease (Xiong et al., 2007). When there is a host immune response due to 
periodontal disease, the fetus is at risk of attack by inflammatory cytokines and 
microbial organisms. These cytokines enter the blood stream if the immune 
system is not able to keep the infection localized leading to risk of placental 
infection, still birth, and pre-term delivery results (Bobetsis et al., 2006). 
Treatment of periodontal disease during pregnancy has been shown to help 
decrease the risk of still birth and pre-term delivery (Wimmer and Pihlstrom, 
2008).  
 
Renal disease is becoming more prevalent and can be fatal if a kidney transplant 
is not performed. Chronic disease of the kidneys and the treatment for this 
condition has a major effect on the oral tissues (Craig, 2008). Patients who are 
treated for end stage renal disease with hemodialysis are at greater risk for 
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periodontal disease. Uremic dysfunction, all of the illnesses associated with renal 
failure, is associated with dysfunction of the immune system. Defects in 
lymphocytes and monocytes, precursors of macrophages, will result in 
inflammation of the gingiva. The end renal failure population also has a higher 
risk of diabetes mellitus. Diabetes is also associated with a high incidence of 
gingival inflammation when looking at the general population (Levine, 2013) 
 
Inflammatory bowel syndrome is a chronic disease characterized by inflammation 
of the intestine and causes a variety of symptoms ranging from diarrhea to 
malnutrition because reduced absorption. Patients with inflammatory bowel 
syndrome, IBS, show a higher incidence of lesions in the oral cavity. In one 
study, 107 patients being treated for IBS were profiled. Over 93% of the patients 
studies showed probing depths of greater than 4mm (Flemmig et al., 2008). 
These results can be attributed to the large quantity of anti-inflammatory 
medications administered to IBS patients. The medications depress the activity of 
neutrophils, preventing the immune system from functioning at capacity. The 
decreased activity of the immune system will result in an increased number of 
microbial organisms in the oral cavity. 
 
Alzheimer’s disease is the leading cause of dementia affecting persons over 65 
years of age. The cause of Alzheimer’s disease is still unknown today but the 
debilitating affects range from psychiatric symptoms, memory loss and language 
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difficulty, to difficulties performing daily activities (Burns and Iliffe, 2009). Kamer 
et al. (2008) introduced the idea of chronic periodontitis contributing to the 
progression of Alzheimer’s disease. Periodontal disease is associated with years 
of pro-inflammatory cytokines release which leads the body to respond to these 
cytokines through inflammation. These excess periodontal cytokines can cross 
the blood-brain barrier and cause inflammation in the brain. There are several 
bacteria mainly found in periodontal disease patients that are known to invade 
other tissues. These bacteria are A. actinomycetemcomitans, Porphyromonas 
gingivalis, and Treponema (Kamer et al., 2008). Their ability to invade other 
tissues makes the brain susceptible for attack. 
Since immune therapy has been successful in the treatment of diseases such as 
cancer, many researchers have speculated that a similar approach may be 
utilized to promote the reversal of periodontal disease. Since nicotine products 
are a major contributor to periodontal disease, studying the effects of immune 
therapy on smoking periodontal patients can be very beneficial. Can 
immunotherapy reverse the effects that the immune system has on the gingiva? 
This is the current topic under investigation in this paper. 
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SPECIFIC AIMS  
 
It has been well established that smoking cigarettes is correlated with an 
increased risk of the development of periodontal disease. Periodontitis is 
associated with a compromised immune system, due to partially functioning 
macrophages as well as decreased levels of cytokines. In order to have a full 
functioning immune system, all components, such as macrophages and 
cytokines, need to be working at their maximum capacity. Smoking has been 
linked to a compromised immune system thus any deficiency can therefore lead 
to inflammation of the gingival tissue promoting poor oral health and ultimately 
leading to the degradation of systemic health.  
 
The goal of the current study is to review the published literature to see if there is 
evidence of improvement of periodontal disease following immune therapy in 
individuals who have previously or who currently smoke. Specifically, the study 
will evaluate the regulation of the mTOR pathway and oral administration of 
immune-therapy drugs such as Lamividine. Following review, we hope to 
conclude that there is solid evidence supporting this therapeutic approach and 
propose further studies aimed at enhancing the immune system of individuals 
who smoke. 
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PUBLISHED STUDIES 
 
The association of periodontal diseases with individuals who smoke is well 
documented (Page and Kornman, 1997; Tomar, 2000; Manakil, 2012). 
Approximately 51% of individuals who are diagnosed with periodontal diseases, 
are smokers, or have smoked for a prolonged period of time (Tonetti, 1998). 
They have an increased risk (2-3 times) of developing some form of periodontal 
disease. The severity of periodontal diseases has also been associated with the 
quantity of cigarettes smoked, so therefore is considered, “dose-dependent”. 
Individuals who smoke more than ten cigarettes a day, show signs of faster 
disease progression than those who smoke less or who don’t smoke at all 
(Tonetti, 1998). 
 
An older study (1973) by Caveliere et al. measuring the amount of recovery time 
it takes for the mouse to recover from cigarette smoke, demonstrated depressed 
levels of leukocytes directly after smoking. The humoral response was impaired 
beyond that seen in leukocytes and the response of the spleen was also 
depressed.  The leukocytes in those who smoked for forty-two weeks 
researchers followed by an additional sixteen weeks from the point of cessation 
were  measured in the lungs and in the peripheral blood. After sixteen weeks, the 
levels of leukocytes showed a significant increase. Measurement directly after 
the 42 week period showed a level of 10^6 leukocytes per cell preparation. When 
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the number of leukocytes were measured after the 16 week period of non-
smoking, concentration of the per-cell preparation was found to be 10^8. There 
was no detectable difference in the control mice at any time point. The draining of 
lymph nodes and the leukocytes of the respiratory tract had a depressed activity 
after the period of smoking but gradually improved after cessation (Caveliere et 
al., 1973). 
 
The micro-biome in the subgingival margin showed that Fusobacterium, 
Prevotella, and Selenomonas were found more abundant in smokers (Bizarro, 
2013). The genera of bacteria which were more abundant in non-smokers were 
Peptococcus and Capnocytophage, are summarized in Table 3. This led Bizarro 
to hypothesize the bacteria present in smokers played a major role in periodontal 
disease progression. When comparing smokers and non-smokers, 80% of the 
smokers had a lower diversity of bacteria in their micro-biome. The less diverse 
bacteria lead to the loss of the ability of ligaments to attach to one another in the 
oral cavity. Bacteria in non-smokers were seen to be located lower on the 
taxonomic chart, associating them with a higher prevalence of disease (Bizarro, 
2013).   
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Table 3: Genera of Bacteria Present in Non-Smokers. Table taken from 
Bizarro, 2013.   
 
 
Bacterial species Gingivitis Chronic Periodontitis 
Aggressive 
periodontitis 
   Localized Generalized 
Aggregatibacter 
actinomycetemcomitans  
 + + + 
Campylobacter rectus + +  + 
Capnocytophaga +  + + 
Cryptobacterium curtum  +   
Eikenella corrodens + + + + 
Enterobacteriaceae  + +  
Eubacterium saphenum  +   
Fusobacterium nucleatum + + +  
Micromonas 
(Peptostreptococcus) 
micros 
 + +  
Mogibacterium 
(Eubacterium) 
timidum 
 +   
Peptostreptococcus 
anaerobius 
+ +   
Pophyromonas 
endodontalis 
 +   
Porphyromonas gingivalis + +  + 
Prevotella intermedia + + + + 
Slackia (Eubacterium) 
exigua 
 +   
Tannerella forsythia  +  + 
Treponema amylovorum  +  + 
Treponema denticola + +  + 
Treponema 
lecithinolyticum 
   + 
Trepo ema maltophilum  +   
Treponema medium + +   
Treponema pectinovorum + +  + 
Treponema socranskii + +  + 
Treponema vincentii + +  + 
Veillonella parvula +    
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Zeidel in 2002, showed individuals who smoked displayed an increased number 
of macrophages in their lungs. The additional macrophages were recruited to the 
site of insult and not fully functional due to the suppressed immune system 
brought on by smoking and nicotine use. The macrophages also have a 
decreased quantity of cytokine production and deployment. Additionally, smokers 
show an increased amount of neutrophils in the lung and in the blood all 
throughout the body. These neutrophils show an enhanced amount of oxygen 
metabolism and are not able to regulate extracellular proteases. Zeidel was able 
to show that the number of natural killer cells and B-cell proliferation decreased. 
This reduced B-cell proliferation causes antigen switching to also be affected. T-
cells, which are exposed to smoke in the lung, show a reduced amount of 
proliferative function. Both CD4 T-cells and CD8 T-cells show a reduced function 
in smokers. An increased level of serum IgE was exhibited in both active and 
passive smokers. (Ziedel et al., 2002) 
 
Smokers show a decreased amount of natural killer cells in the peripheral blood. 
They also show an increased production of several cytokines. The pro-
inflammatory cytokines include tumor necrosis factor-alpha, IL-1 beta and IL-1ra. 
When Barbour in 1997 compared smokers to non-smokers, all of these pro-
inflammatory cytokines show an enhanced proliferative function when they are 
exposed to mitogens (Barbour et al., 1997). 
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Carolina in 2001, carried out a study which treated Hepatitis B patients with a 
drug called, Lamivudine. This study displayed a significant set of results. All of 
the patients who were treated with this immune therapy showed improved results 
in cytotoxic T-cell (CTL) response.  Hepatitis-B patients who showed little or no 
CTL activity pre-treatment, showed the most significant increase in cytotoxic T-
cell production. There were CTL responses in four patients who showed no CTL 
responses before treatment and enhanced CTL responses in those who showed 
a minimal amount of CTL response. After 1 month of treatment in individuals who 
showed no signs of CTL activity, there was an increase in their CTL levels. 
Patients who showed minimal levels of CTL, required at least four months of 
Lamivudine treatment to show signs of CTL enhancement (Boni, 2001). 
 
The CD8+ T-cell activity, which was measured through the observation of 
different types of tetramers, showed an increase after lamivudine treatment was 
administer. The amount of CD8+ T-cells fluctuated during the different times of 
observations. The CD8+ T-cells contain different types of epitopes; core, 
envelope, and polymerase epitopes. The frequencies of these epitopes were also 
shown to increase after lamivudine treatment. Different types of tetramers were 
also evaluated and the activation marker frequencies also increased after 
therapy (Boni, 2001). 
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A study completed in 2013 by Katholnig et al., discovered that the mTOR 
signaling pathway is responsible for both pro-inflammatory and anti-inflammatory 
responses. Mice with a deletion in the raptor protein, a protein in the mTOR 
signaling pathway, were more prone to develop colitis (Figure 9). When the 
inhibition of the mTORC1 pathway was reversed, the amount of pulmonary 
injury, when exposed to tobacco, dramatically increased.  Katholnig has also 
speculated that the mTORC2 pathway negatively affects the release of pro-
inflammatory cytokines (Katholnig et al., 2013). 
 
One of the most important regulators in the activation of the mTORC1 pathway is 
the phosphatidylinositol 3 kinase (PI3K) protein. When the concentration of the 
PI3K protein is pharmacologically altered in mice, an increase in the number of 
death was observed because of the excess amount of pro-inflammatory 
cytokines released. Katholnig et al. has also done pharmacological studies 
demonstrating that even without the PI3K protein, the TSC1 and the mTOR 
proteins suffice to reduce the amount of pro-inflammatory cytokines released. 
These two pathways can be integrated to carry out the normal PI3K inhibition 
(Katholnig et al., 2013). 
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Figure 9:  The mTOR signaling pathway.  The schematic illustrated the 
involvement of mTOR e for both pro-inflammatory and anti-inflammatory 
responses.  Figure taken from Katholnig et al., 2013. 
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A regulator other than the PI3K protein is the COT protein, also known as the 
cancer Osaka thyroid oncogene protein. A deficiency in the COT protein 
displayed a decrease in the activation of the mTORC1 pathway, therefore 
increasing inflammation. Katholnig tested a few vaccinations which, showed an 
improvement in the production of the CD8+ cells and the anti-inflammatory/anti-
tumor immunity response  (2013). 
 
The mTOR pathways are responsible for inhibiting and activating the release of 
pro-inflammatory cytokines. An increase in pro-inflammatory cytokines is through 
the deletion of a raptor protein, alteration of the PI3K protein, and a deficiency in 
the COT protein. The mTOR signaling pathway, shown in Figure 9, is 
interconnected. An alteration in one of the proteins or pathways can alter the 
whole pathway. 
 
One study evaluated the effects of smoking on the gingival crevicular fluid levels 
on periodontal disease patients. The components of crevicular fluid are pro-
inflammatory cytokines such as IL-6 and TNF-alpha. Smoking was not shown to 
effect gingival crevicular fluid, therefore having no effect on pro-inflammatory 
cytokines. But the amount of attachment loss in the gingival margin and the 
amount of plaque showed an increase (Erdemir et al., 2004). 
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The mTOR pathway is strongly correlated with the amount of inflammation in 
periodontal tissue when nicotine products are used. The different pathways 
involved control the release of either pro-inflammatory or anti-inflammatory 
cytokines. Alterations of proteins, such as PI3K, in the mTOR pathway displayed 
a dramatic increase in inflammation. A deficiency in the COT protein showed a 
decrease in the activation of the mTORC pathway, eventually leading to an 
increase in inflammation. Administration of Lamividine to Hepatitis B patients, 
displayed an increase in the number of CTL present. Future research is a 
necessity to build upon the already built foundation of knowledge on 
immunotherapy, the use of nicotine products, and other diseases involving a 
depressed immune system.  
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DISCUSSION 
 
The furthering of research in immunotherapy for periodontal disease is 
imperative because of its success in a variety of areas in the medical field. With 
an increased use of tobacco products in today’s society, it is essential for 
researchers to find alternative therapies to reverse the effects of advancing 
periodontal disease.  
 
Immune therapy in cancer patients is a very promising treatment. A number of 
immunotherapy drugs have led to improved outcomes for individuals with 
advanced stage melanoma. Melanoma cells contain a protein, PD-L1, located on 
their surface that allows them to escape detection from the immune system. 
Researchers have developed a new drug, named Lambrolixumab, to either block 
this PD-L1 protein on the immune cell or on the melanoma cell itself. This type of 
immune therapy has been able to display positive results in more than 35% of 
the patients treated (American Cancer Society, n.d., Hamid et al., 2013). 
 
Allergies are very common and can affect essentially any population. Allergy 
immunotherapy is a technique used by many physicians to lessen the severity of 
a future allergic reaction. The physician administers small doses of the specific 
allergen the patient is sensitive to, gradually increasing the dose bi-weekly. 
These incremental increases allow the body to form a “blocking anti-body”, 
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making the individual less sensitive to future allergen attacks. Symptoms are 
reduced significantly and the inflammation associated with such allergic reactions 
is not as prominent. The patient’s own immune system is “trained” to release less 
inflammatory cytokines (American College of Allergy, Asthma, and Immunology, 
n.d.). 
 
Immune Therapy in Periodontal Disease Patients 
Immune therapy for periodontal patients has slowly progressed. A study done by 
Rezki et al. in 1991, looked at the effects of immune therapy on periodontal 
disease patients. Immune therapy was administered orally for a period of three 
weeks and demonstrated a significant decrease in inflammation, pain, and other 
symptoms associated with periodontal disease.  
 
Another condition which has had positive results with immunotherapy is 
rheumatoid arthritis.  These patients have an increased level of the pro-
inflammatory cytokine TNF, leading researchers to study periodontal disease 
patients with rheumatoid arthritis. Forty subjects were studied and administered 
the anti TNF-alpha immunotherapy drug, infliximab. The quantity of plaque 
recorded after treatment with infliximab significantly decreased. This decrease in 
plaque concentration lead researchers to conclude that the TNF-alpha blockade 
medication used for rheumatoid arthritis patients can also be beneficial for 
periodontal disease patients (Okada et al., 2013). Additionally, rheumatoid 
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arthritis patients generally have more gingival inflammation than healthy control 
individuals. Salivary levels of matrix metalloproteinase-8 (MMP-8) IL-beta and 
TNF dramatically decreased when administered anti-TNF-alpha antibody therapy 
(Mirrielees et al., 2010). 
 
Promising Future for Immunotherapy 
The effects of the immune system after prolonged tobacco use have been under 
analysis. Individuals who have smoked for long periods of time have been shown 
to either have an increased presence of pro-inflammatory cytokines or amount of 
plaque. These cytokines include tumor necrosis factor, IL-1ra, and IL-beta. When 
these cytokines were retrieved from the peripheral blood, they showed an 
enhanced proliferative function. This was due to the excessive exposure of 
mutagens present in the nicotine products (Barbour et al., 1997). Anti-TNF-alpha 
immune therapy used for rheumatoid arthritis patients can help reduce the 
amount of circulating pro-inflammatory cytokines (Okada et al., 2013). Since this 
study was targeting rheumatoid arthritis patients with periodontal disease, an 
altered study which only studies periodontal disease patients, should be carried 
out to observe if the same results are attained and periodontal disease improves.  
 
The micro-biome of individuals with periodontal disease differs greatly than those 
who have healthy gingiva. They are shown to have higher levels and different 
types of bacteria lining their gingival margin (Bizzarro, 2013). A number of 
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immunotherapy drugs, such as infliximab, are able to decrease the amount of 
plaque in the oral cavity (Okada et al., 2013). A decrease in the amount of plaque 
will help lessen the chance of periodontal disease progression.  
 
As discussed, individuals who smoke show an increase in the chromogranin A 
protein release. Because this protein basically attacks the person’s body directly, 
immune therapy may work through signaling by halting its release (Sadaoka, 
2013). Since signaling pathways can be both inhibited and activated, therapy 
could inhibit the signaling pathway which tobacco activates. Since immune 
therapy signals the mTOR pathway to increase CD8+ levels, smokers may show 
the best response with this kind of therapy. The mTOR pathway is responsible 
for the activation and inhibition of pro-inflammatory cytokines (Katholnig et al., 
2013). Since individuals who smoke shows signs of increased inflammatory 
cytokines in their peripheral blood, therapy directed toward this type of signaling 
pathway may be beneficial and should be investigated. Immune therapy altering 
one of the proteins in the pathways may show a decrease in the amount of 
inflammation.  
 
Hepatitis B patients show suppressed levels of cytotoxic T-cells, an issue that is 
also present in periodontal disease patients. Administering Lamvidine to these 
patients has been shown to lead to an increase in CTL levels (Boni, 2001).  
Immunotherapy used for Hepatitis B patients may be another strong option for 
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patients with periodontal disease in order to enhance their immune system.  The 
depressed activity of macrophages and cytokines retrieved from the alveolar 
space of the lung and the oral cavity can be enhanced through this type of 
therapy (Ziedel, 2002). Since immune therapy is shown to enhance the activity of 
T-cells, B-cells, macrophages, and other mediators, this type of therapy is an 
ever growing field that could be very beneficial for periodontal disease patients.  
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FUTURE DIRECTIONS 
 
Since smoking is a large contributing factor to periodontitis, preventative 
measures should be taken to decrease the frequency as well as the number of 
individuals who smoke.   
 
Educational Changes  
Programs should be implemented to educate young adults about the detrimental 
effects that smoking has on both systemic and oral health. The Center for 
Disease Control and Prevention has stated that the younger age groups have a 
higher rate of smoking than any other age group in 2011 (American Cancer 
Society, 2011). In order to prevent younger age groups from beginning to smoke, 
education starting from a young age needs to be implemented in schools. 
Experts in this topic should travel to middle schools and high schools and lecture 
in health classes. With the help of dedicated faculty and staff, a difference can be 
made in the number of future young adult smokers. 
 
Education for parents is also very important. Parents play a major role in the 
decisions their children make. Adults, who have not had the proper education 
about the detrimental health effects of smoking, are not able to pass on healthy 
habits to their children. Brochures and prevention classes should be 
administered in doctor and dental offices so these parents can educate 
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themselves and their children. Prevention of periodontal disease stems from the 
knowledge of how to prevent it and knowing the detrimental effects that smoking 
can cause not only to the gingiva, but to the body as a whole. 
 
Future Research 
Nicotine products cause many changes in the body leading to enhanced pro-
inflammatory cytokines in the peripheral blood and the alveolar space in the 
lungs (Barbour et al., 1997). Much of the research previously carried out was 
done was on rheumatoid arthritis patients. Anti-TNF-alpha immune therapy drugs 
were administered to rheumatoid arthritis patients who developed periodontal 
disease (Okada et al., 2013). Future research should see if these immune 
therapy drugs work on patients not suffering from rheumatoid arthritis. There may 
be a factor which rheumatoid arthritis contributes that can enhance the effects of 
the anti-TNF-alpha immune therapy drugs. 
 
There has been much research about immune therapy for cancer patients and its 
effects on the immune response (American Cancer Society, 2013). Knowing how 
to manipulate an individual immune response to secrete pro-inflammatory and 
anti-inflammatory cytokines in periodontal patients could be very useful in 
reversal of advanced stages of periodontitis patients (Katholnig, 2013). Patients 
who have been diagnosed with advanced periodontal disease can be tested for a 
deletion in either the PI3K or the COT protein. Deletions in both of these proteins 
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can lead to enhanced release of inflammatory cytokines causing more 
inflammation in periodontal disease patients. Developing therapies which find 
alternative pathways to control the release of these inflammatory cytokines may 
be key to finding a successful therapy for reduction of periodontitis in patients. 
 
When an individual smokes a cigarette, the body is exposed to harsh chemicals 
creating a detrimental environment. This assault on the body will result in the 
release of secretory proteins such as chromogranin A (Barbour et al., 1997, 
Sadaoka et al., 2013).  The only way the body can respond is through fighting 
back with the immune system because of the excessive inflammation, ligament 
loss, and increased number of bacterial organisms. Development of a therapy to 
regulate the amount of release of chromogranin A can be very beneficial to stop 
the immune system from deploying excess immune components (Sadaoka et al., 
2013).  Decreasing the amount of deployment of these proteins will assist with 
decreasing the amount of inflammation in the gingiva. 
 
The micro-biome of an individual who smokes differs from non-smokers. 
Fusobacterium, Prevotella, and Selenomonas were found more abundant in 
smokers. These results led researchers to hypothesize the bacteria were major 
contributors to the progression of periodontal disease. These bacteria are lower 
on the taxonomic chart, which associates them with a higher prevalence of 
disease (Bizzarro, 2013). Research on the use of antibiotics directed against the 
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specific bacteria should be studied on both healthy adult and periodontal disease 
patients. Since the bacteria increase dramatically during gingival inflammation, 
antibiotic therapy should be considered as a treatment method. When there is an 
increase in certain types of bacteria, they tend to cluster together in a specific 
orientation (Socransky et al., 2008). Use of antibiotics against the increased 
concentration of gram-positive in the gingival margin can show to be very 
beneficial.  
 
The concentration of plaque has been shown to increase significantly after 
inflammation of the gingiva is noted (Rudiger et al., 2001).  Formation of plaque 
due to an increase in inflammation can be due to two different mechanisms. First,  
the increased secretion of protein by the ginginal margin, leads to more rapid 
plaque formation. Additionally, there is also a shift from gram-negative bacteria, 
which do not contain filaments and rods, to gram-positive bacteria that do contain 
filaments and rods (Rudiger et ., 2002).  
 
Since we have discussed the increase in gingival inflammation of individuals who 
smoke cigarettes, extra measures should be taken to decrease plaque 
concentration in individuals who smoke. Prophylactic cleanings are usually 
administered two times a year for those who have healthy gingiva. More research 
should focus on the benefits of increased prophylaxis treatments in periodontal 
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disease patients. The quantity and type (gram-positive or gram-negative) of 
gingival bacteria should be noted along with the extent of gingival inflammation.    
 
Final Conclusions 
The effects of tobacco on gingival tissue can lead to a variety of oral and 
systemic concerns. The increase of plaque due to tobacco use causes an 
increase in microbial bombardment on the oral cavity. The increase in host 
inflammatory response can cause both bone and connective tissue catabolism. 
The decrease in function of the compromised immune system leads to increased 
release of pro-inflammatory cytokines such as tumor necrosis factor alpha  
leading to inflammation of the gingival tissue.  
 
The formation of of plaque can lead to the progression of periodontal disease. 
Calcification of excessive amounts of plaque will lead to calculus, which can 
result in an even greater extent of gingival inflammation leading to the formation 
of gingival calculus and gingival recession. Subgingival calculus is associated 
with formations of pockets in the gingival margin. Periodontal disease 
progression increases the number and extent of pocketing in the gingival margin.  
 
Periodontal disease does not only affect the oral cavity, but is also associated 
with many systemic diseases. Respiratory infections such as pneumonia, renal 
diseases, unfavorable pregnancy outcomes, inflammatory bowel syndrome and 
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Alzheimer’s disease have all been found to be linked to periodontal disease. The 
high concentration of bacteria is a large contributor to these disease states. In 
order to affect other areas of the body, the bacteria must be displaced from the 
oral cavity.  
 
Further research on immune therapy, which has been shown to successful in 
other disease states, will not only be beneficial for the oral cavity, but for overall 
systemic health. Both immune and bacterial components should be taken into 
consideration when developing therapies for periodontal disease. Researchers 
should model therapies after existing therapies that have been successful for 
other diseases.  Similar to the immunotherapy studies with lamvidine (Hepatitis 
B), lambrolixumab (melanoma) and infliximad (oral plaque) there is much 
optimism in the development of future therapies for periodontitis in both smokers 
and non-smokers.  Modulating the immune response induced by Chromagranin 
A or possibly through the use of anti-TNF-alpha therapies which have shown 
success in patients with rheumatoid arthritis also are open to future research. 
The development and testing of bacteria specific antibiotics for Fusobacterium, 
Prevotella, and Selenomonas, more commonly present in may prove to be very 
beneficial.  There are many open avenues for the advancement of future 
treatments but we must also encourage a reduction in future smokers through 
education.  
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